Causes of Thrombosis in Young Patients
In young patients with thrombosis, inherited thrombophilias are the dominant cause, present in approximately 46.9% of cases under age 50, followed by pregnancy/oral contraceptives in young women (18.2% and 13.6% respectively), with approximately 50% of first-time venous thromboembolism cases being unprovoked. 1, 2
Primary Etiologic Categories
Inherited Thrombophilias (Most Common in Young Adults)
The genetic causes account for 25% of screening populations without family history and up to 63% of familial cases 1:
Most Common Genetic Defects:
- Factor V Leiden (FVL) - Most prevalent inherited coagulation disorder, found in 90-95% of patients with activated protein C resistance 1
- Prothrombin G20210A mutation - Associated with 30% elevated prothrombin levels 1
- MTHFR C677T polymorphism - Most common thrombophilic defect in young adults, associated with hyperhomocysteinemia 3
Less Common but Higher Risk Defects:
- Antithrombin III deficiency
- Protein C deficiency
- Protein S deficiency
- Factor XIII deficiency
These account for 5-10% of thrombosis patients but carry more quantifiable VTE risk 1
Acquired Risk Factors Specific to Young Patients
Hormonal/Reproductive (Young Women):
- Oral contraceptives - Most venous thrombotic events in young women are attributable to OCs 4
- Pregnancy and postpartum period - Creates hypercoagulable state with increased coagulation factors 5
- Estrogen replacement therapy, tamoxifen, raloxifene 1
Other Acquired Factors:
- Prolonged immobilization (even short-term, ≥1 week) 6
- Surgery and trauma 1
- Central venous catheters - Account for 50-80% of pediatric VTE 7
- Malignancy - 4-7 times higher VTE incidence than healthy individuals 7
- Smoking 1
- Obesity (BMI >95th percentile) 7
- Infection and systemic inflammation 7
Antiphospholipid Antibody Syndrome
The association between antiphospholipid antibodies and stroke is strongest for young adults under 50 years, with prevalence of 9.7% in ischemic stroke patients 8. This represents an important acquired thrombophilia with both venous and arterial manifestations.
Anatomic Abnormalities
Developmental anomalies of the inferior vena cava should be considered in young adults with spontaneous proximal venous thrombosis, especially when recurrent or resistant to anticoagulation 9, 2. These include membranous obstructions and other congenital IVC abnormalities.
Critical Clinical Patterns
Multifactorial Nature
Thrombosis in young patients is typically multicausal - more than one risk factor is usually required before thrombosis occurs 1, 4. The younger the individual, the more risk factors are typically needed: children often require 3-4 factors, young adults often 2 or more 4.
In 56% of young patients with thromboembolic disease, either congenital etiology or antiphospholipid antibodies are identified 10. However, approximately 50% of first-time VTE cases appear unprovoked 1.
Age-Specific Considerations
Pediatric patients: Thrombosis appears almost exclusively with venous catheters, except for neonatal renal vein thrombosis 4. The age distribution is bimodal, with peaks in infancy (20% of pediatric VTE) and adolescence (50% occurring ages 11-18) 7.
Young adults (<50 years): Inherited thrombophilia prevalence is three times higher than in older patients 2. Family history of VTE is significantly more common in those with congenital risk factors 10.
Common Pitfalls
Do not dismiss thrombosis workup in young patients with transient acquired risk factors - young adults should still be screened for thrombophilia even when pregnancy, OCs, or immobilization are present 2
Recognize gene-environment interactions - inherited thrombophilias often interact with environmental factors to provoke thrombosis 1
Consider paradoxical embolism - in young stroke patients with patent foramen ovale, prothrombin G20210A mutation (but not FVL) is significantly more common 8, 11
Exclude IVC abnormalities in young patients with spontaneous proximal venous thrombosis, particularly when recurrent 2